Drug Week articles from October 2004

Drug Week archives from October 2004

Erythromycin combined with common drugs may increase cardiac death risk.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Patients who took the antibiotic erythromycin with medications that inhibit CYP3A drug enzymes, such as certain calcium-channel blockers, certain antifungal drugs and some antidepressants, had a...

Neramexane did not demonstrate statistical significance in recent AD trial.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced that in a preliminary analysis, data from the first phase III study of the investigational Alzheimer disease (AD) treatment, neramexane, failed to achieve...

Results from Thelin and Viagra drug interaction study announced.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (ENCY) announced results from a 12-subject drug-interaction study of Thelin (sitaxsentan) and Viagra (sildenafil) demonstrated a minor pharmacokinetic drug-drug interaction. ...

Milestone II Registry reaffirms positive safety outcomes stent system.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc.'s, (ANPI, ANP) corporate partner, Boston Scientific, announced 6-month clinical findings from the European component of its Milestone II Registry. Boston Scientific...

West Nile Virus clinical study initiated.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Avi BioPharma, Inc., (AVII) announced that it will initiate a clinical trial with its Neugene antisense drug candidate, Avi-4020, for the treatment of patients with acute West Nile virus disease who...

Promising results announced for AdVac.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Dutch biotechnology company Crucell, NV, (CRXL) and Harvard Medical School announced results of a joint study supporting novel vaccine vectors developed by Crucell. The results were outlined in a...

SIVmac Gag p27 capsid protein gene expression in potato reported.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have achieved SIVmac Gag p27 capsid protein gene expression in potatoes. According to published research from the United States, "A cDNA encoding the simian immunodeficiency virus type...

Osteopontin is expressed in the lungs of acute respiratory distress syndrome.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. According to recent research published in the journal Lung, "Acute respiratory...

NDA submitted to FDA for acne product.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that on August 31, 2004, together with co-development partner Fujisawa Healthcare, Inc., they submitted a New Drug Application (NDA) to the U.S. Food and Drug...

Acne treatments do not increase sunburn risk.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Azelaic acid, benzoyl peroxide, and adapalene do not seem to enhance UVB erythema, researchers say. According to recent research from Turkey, "The enhancing effects on UVB erythema of topical...

Serum levels of 20 kilodalton human growth hormone key in acromegaly patients.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- High serum levels of 20K-hGH might elicit a chronic change in the clearance kinetics of 20K-hGH and increase the proportion of 20K-hGH in acromegalic patients. "Circulating human GH (hGH) consists...

Effects of cannabis on information-processing speed explored.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The effects of cannabis on information-processing speed were recently studied by Australian researchers. According to the recent research, "Despite extensive research on the effects of cannabis on...

Federal study shows drug treatment among 12-17 year olds up 65% over decade.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The number of admissions to substance abuse treatment for adolescents ages 12 to 17 increased again in 2002, continuing a 10-year trend. These data were released in the "Treatment Episode Data Set:...

Biopharmaceutical company receives clearance for Remoxy clinical trials.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Pain Therapeutics, Inc., (NASDAQ:PTIE) announced that it has received regulatory clearance to initiate clinical studies with Remoxy in the United States. The company had been conducting clinical...

Prerecorded presentation on HANDS protocol available online.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Hythiam, Inc., (AMEX:HTM) announced that a lecture given by Crescenzo Pisano, MD, and medical director of the Peninsula Recovery Center at Little Company of Mary San Pedro Hospital (LCM), is available...

Study documents benefits of adolescent substance abuse treatment.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- A study published in a leading scientific journal found that adolescents treated at one of Phoenix House's teen treatment centers demonstrated substantial reductions in drug use and unlawful behavior...

Substance P may play role in hypersensitivity reactions induced by paclitaxel.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Substance P may play a role in hypersensitivity reactions induced by paclitaxel, suggest pharmacologists at Kyushu University, Japan. "The role of substance P in adverse pulmonary reactions induced...

FDA advisory committee reviews clinical submission for Macugen.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Nektar Therapeutics (NKTR) reported that Eyetech Pharmaceuticals, Inc., (EYET) and Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration's (FDA) Dermatologic & Ophthalmic Drugs Advisory...

FDA advisory committee reviews Macugen data.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Eyetech Pharmaceuticals, Inc., (EYET) and Pfizer, Inc., (PFE) announced that the U.S. Food and Drug Administration's (FDA) Dermatologic & Ophthalmic Drugs Advisory Committee has met to review the...

Buzz in the air can cause stinging insect allergies, asthma group advises.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- As summer comes to an end, you may have noticed an increase in the number of stinging insects, such as yellow jackets and wasps, flying through the air. For most people, getting stung results in...

Wheat gluten causes dendritic cell maturation and chemokine secretion.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Wheat gluten causes dendritic cell maturation and chemokine secretion, according to a new report. According to the research published in the Journal of Immunology, "Wheat gluten causes gut...

FDA approves Clarinex syrup for allergies and hives in children.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) announced that the U.S. Food and Drug Administration (FDA) has approved the use of Clarinex (desloratadine) Syrup for the relief of symptoms associated with seasonal allergic...

Pharmaceutical company changes symbol from "CBSC" to "CLSC".
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Cobalis Corp. (CBSC), a pharmaceutical company specializing in the development of anti-allergy medications, announced that its trading symbol changed to CLSC at the start of trading on August 27, 2004....

12-Lipoxygenase blockade protects neurons from peptide-induced degeneration.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- 12-Lipoxygenase blockade protects neurons from peptide-induced degeneration. "The cyclooxygenase (COX) and lipoxygenase (LOX) pathways belong to the eicosanoid synthesis pathway, a major component...

Acetylcholine minor role in prepulse inhibition regulation in Alzheimer disease.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Acetylcholine has only a minor role in prepulse inhibition regulation in Alzheimer disease. According to published research from Denmark, "Prepulse inhibition (PPI) is used as a measure for...

Alzheimer researchers eye brain buildup.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- How to prevent a sticky gunk from clogging up, and probably killing, the brain cells of Alzheimer patients is the newest focus in the fight against the disease. Half a dozen companies are developing...

Influence of O-3/O-2-pneumoperitoneum as an oxidative stressor analyzed.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The influence of O-3/O-2-pneumoperitoneum has been studied as an oxidative stressor on duration of anesthesia, loss of different reflexes and cytokine mRNA expression. "We analyzed the effect of...

GENASIS phase IIb clinical trial for severe cardiovascular disease begins.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Corautus Genetics, Inc., (CAQ) announced the commencement of its phase IIb clinical trial to evaluate the safety and efficacy of vascular endothelial growth factor-2 (VEGF-2) for the treatment of severe...

Angiogenic response is heightened in collagen XVIII/endostatin-null mice.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Angiogenic response is heightened in collagen XVIII/endostatin-null mice. According to a study from the United States, "endostatin, a proteolytic fragment of basement membrane-associated collagen...

Caveolin-1 is critical for vascular remodeling following limb ischemia.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Caveolin-1 is critical for vascular remodeling following limb ischemia. According to recent research published in the journal Circulation Research, "nitric oxide (NO) is a powerful angiogenic...

Most widely used stress modality for CMR perfusion studies is adenosine.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Cardiovascular magnetic resonance and the role of adenosine pharmacologic stress were the focus of a recent report. "As an advanced imaging modality, cardiovascular magnetic resonance (CMR) offers...

Superoxide dismutase gene transfer improves impaired aortic relaxation.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Superoxide dismutase gene transfer improves impaired aortic relaxation. According to a study from the United States, "lipopolysaccharide (LPS) impairs vascular function, in part by generation of...

Inhibition may aid protective effect of IL-10 on postangioplasty restenosis.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo. According to published research from France, "The anti-inflammatory cytokine IL-10 inhibits intimal hyperplasia after...

Captopril works without affecting cardiac sympathetic neurotransmission.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Captopril enhances cardiac vagal but not sympathetic neurotransmission in pithed rats. According to a study from Japan, "The effect of captopril on neurally evoked bradycardia and tachycardia was...

Enalapril and ramipril provide similar clinical benefits in animals.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The benefits of ACE inhibitors with tissue-active levels were recently examined in the cardiac-compromised animals. According to published research from Australia, "Angiotensin converting enzyme...

Predictors of leptin in adolescent girls with anorexia identified.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have identified hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa. "Anorexia nervosa (AN) is...

U.S. FDA approves ciprofloxacin to manage postexposure inhalational anthrax.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved ciprofloxacin hydrochloride for the management of postexposure inhalational anthrax. According to a study from the United States, "In August...

Dinitroanilines disrupt protozoan microtubules by binding alpha-tubulin.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Dinitroanilines disrupt protozoan microtubules by binding alpha-tubulin. "Protozoan parasites are remarkably sensitive to dinitroanilines such as oryzalin, which disrupt plant but not animal...

Nisin forms cage-like structure around bacterial cell wall.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Many antibiotics kill bacteria by weakening their cell walls. However, some bacteria are finding ways to prevent the destructive action of the antibiotics, and drug-resistant pathogens have become an...

Pharma company completes hiring of sales team for FACTIVE.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has completed the hiring of its sales force and sales leadership team for its U.S. Food and Drug Administration-approved FACTIVE (gemifloxacin...

Optimal level of anticoagulation remains matter of debate.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- What are the remaining questions regarding monitoring of heparin therapy during extracorporeal bypass? According to published research from France, "Cardiac surgery with extracorporeal circulation...

Use of antidepressants by children debated after shooting in Houston.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The case of a 10-year-old boy accused of killing his father is fueling ongoing concerns about the use of antidepressants by pediatric patients. Deborah Geisler, the boy's mother, said a psychiatrist...

Bioscience company files patent for silver dihydrogen citrate formulations.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- PURE Bioscience (OTCBB:PURE) announced that it has filed a utility patent application to protect its proprietary silver dihydrogen citrate disinfectant in combination with other antimicrobial compounds,...

Double-stranded complexes increase antisense oligonucleotide uptake.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Double-stranded complexes increase antisense oligonucleotide uptake. "Antisense oligonucleotides were potentially very powerful tools to modulate gene expression. Progress in chemical modification...

Chronic hepatitis C nonresponders are a challenge to clinical management.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Chronic hepatitis C nonresponders are a challenge to clinical management. "A significant proportion of chronic hepatitis C patients fails to achieve sustained virologic response even after treatment...

Impact of genetic variations on treatment of early rheumatoid arthritis studied.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Characterized by inflammation in the connective tissues of the joints, rheumatoid arthritis (RA) can be a painful, crippling autoimmune disease. Traditionally, patients have been treated with...

Allergens, endotoxins don't have same effects in tropical environments.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Indoor concentrations of allergens traditionally associated with asthma symptoms and severity may not be applicable in tropical environments and highly ventilated households. According to a study...

Antimicrobial-coated vascular grafts provide antimicrobial protection.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Antimicrobial-coated vascular grafts provide antimicrobial protection. "The serious medical consequences and costly management of infections associated with vascular grafts have prompted an...

Immune system's neuroprotective response to brain injury analyzed.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Autoreactivities to brain tissue in autism patients may represent the immune system's neuroprotective response to a previous brain injury that occurs during neurodevelopment. According to published...

Genetically modified bone marrow cells produce tolerance to self antigens.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Genetically modified bone marrow cells produce tolerance to self antigens. "The challenge of finding a lasting cure for autoimmune disease(s) has not been met. Although the use of systemic...

Some SCPs are relevant to our understanding of autoimmunity.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Some subcellular particles (SCPs) are relevant to our understanding of autoimmunity, researchers posit. "Firm evidence links the process of apoptosis to the induction of autoimmune disease....

IADR, GlaxoSmithKline Consumer Healthcare sponsor Innovation in Oral Care Awards.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare will sponsor the 2005 Innovation in Oral Care Awards. Competitive awards, up to $75,000, will...

Myeloma research group announces 2004 senior Research and Fellows Awards winners.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- The Multiple Myeloma Research Foundation (MMRF), a private funder of myeloma-specific research, announced the awarding of 20 one-year research grants worth nearly $1.6 million to leading myeloma...

Rapid diagnosis of pharyngitis caused by group A streptococci is vital.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Rapid diagnosis of pharyngitis caused by group A streptococci can reduce the risk of spreading the disease. "Although commercial rapid antigen detection tests (RADTs) are more expensive than blood...

Model system assesses Escherichia coli evolution during stationary phase.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- A model system assesses Escherichia coli evolution during its stationary phase. According to a study from the United States, "The process of evolution by natural selection has been known for a...

Association: German biotech industry sees light at the end of the tunnel.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- After two difficult years, there are more signals in 2004 that trends are turning in the economic situation of the German biotechnology industry. Professor Peter Stadler, chairman of the German...

Newer anticonvulsants for treating bipolar disorder reviewed.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers review newer anticonvulsants for the treatment of bipolar disorder in a recent issue of the Journal of Clinical Psychiatry. According to a study from Canada, "The anticonvulsants...

BMI determines evoked growth hormone responsiveness in healthy male subjects.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Body mass index (BMI) determines evoked growth hormone (GH) responsiveness in normal healthy male subjects. "GH secretion is decreased in obese subjects, whereas age-adjusted IGF-I concentrations...

Diabetic metabolic state affects healing of large bone defects.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Diabetic metabolic state affects healing of large bone defects. According to recent research from Germany, "Insulin-dependent type 1 diabetes mellitus (IDDM) has been shown to after the properties...

Symptoms predictive of death in patients with food-borne botulism reported.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers outline the signs and symptoms predictive of death in patients with food-borne botulism in a recent issue of Clinical Infectious Diseases. According to published research from the United...

Urokinase receptor ligands spoil glioma growth via antiangiogenesis.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Urokinase receptor ligands spoil glioma growth via antiangiogenesis. "Species-specific urokinase receptor (uPAR) ligands with improved pharmacokinetics were generated by site-specific mutagenesis...

iBAC system-mediated gene delivery stifles glioma cell growth.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- iBAC system-mediated gene delivery stifles glioma cell growth. "The expression of genes from genomic loci can be relatively complex, utilizing exonic, intronic and flanking sequences to regulate...

Breast tumor cells may swell in response to tamoxifen methiodide treatment.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Diffusion breast magnetic resonance imaging (MRI) may be applied to the clinical evaluation of breast cancer. "The parameters that characterize the intricate water diffusion in tumors may serve to...

Breast-conserving surgery plus radiation good for older women, too.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Surgery plus radiation therapy is an effective way to treat early breast cancer in women aged 70 and older, according to a new study published in the September 1, 2004, issue of the International...

Prevention study seeks postmenopausal women at high risk for breast cancer.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Healthy, postmenopausal women at high risk for breast cancer may be eligible to participate in a major new international study to determine whether the drug exemestane can prevent the disease. The...

Anti-HER-2 mAbs synergistically kill breast tumor cells.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Anti-HER-2 monoclonal antibodies synergistically kill breast tumor cells. "Trastuzumab (herceptin) and pertuzumab (Omnitarg, 2C4) are recombinant humanized monoclonal antibodies that target...

CRO announces cost reduction initiatives.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced that it has initiated a rationalization and efficiency program to realign employee responsibilities and reduce workforce, as appropriate, in order to reduce the...

Cancer drug maker provides corporate update.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology (ACU) released the company's financial results and a report on its activities for the year ending June 30, 2004. The period under review, and post balance date, has been...

Novo Nordisk A/S completes investment in biopharma company.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Transition Therapeutics Inc. (Transition) (TSX: TTH) announced the closing of a previously announced issuance of 5,000,000 common shares to Novo Nordisk A/S (Novo Nordisk) at a price of $1.20 per share...

Pharmaceutical firm closes EUR12M financing, provides pipeline update.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- BioAlliance Pharma SA, a privately held biopharmaceutical company focused on the field of drug resistance, announced that it has raised an additional EUR 2.0 million to top off its third round of...

Biopharmaceutical firm completes re-incorporation to Delaware.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) reported that it has completed its re-incorporation from the State of California to the State of Delaware. Cellegy's shareholders approved the re-incorporation...

Biotech company adds general counsel, exercises of over-allotment option.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI, CTIC) announced the addition of Richard E. Leigh, Jr., as executive VP and general counsel. Leigh will serve as a member of the company's senior management team...

Biotech company business update includes vaccine development, financing, growth.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Sinovac Biotech Ltd. (SNVBF) has announced updates to its business activities. Sinovac has three vaccines that have completed all three phases of clinical trials: hepatitis A, hepatitis A&B...

China-based pharmaceutical changes trading symbol to "CPICF".
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- China Pharmaceuticals International Corp. (CPICF) announced that effective August 26, 2004, its common stock trades under the symbol "CPICF" on the OTC Bulletin board. The new symbol results from...

Companies agree to discontinue business arrangements on antifungal drug.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Sankyo Co., Ltd and Fujisawa Pharmaceutical Co., Ltd. announced that both companies have mutually agreed to discontinue the licensing and co-development agreements on CS-758, an oral azole antifungal...

Diosynth, Organon integrated to reinforce human pharmaceutical business.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Akzo Nobel announced the intention to integrate its two human pharmaceutical businesses, Diosynth and Organon, into one operating business unit. The integration combines key competences of Diosynth...

GSK acquires Fraxiparine, Fraxodi, Arixtra, and associated manufacturing plant.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline, plc, (GSK) announced the successful acquisition, on a worldwide basis, of the injectable antithrombotic agents Fraxiparine, Fraxodi, and Arixtra, and related assets including a...

Glenmark has acquired two FDA-approved products.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Glenmark Pharmaceuticals Inc., USA, the wholly owned subsidiary of Glenmark Pharmaceuticals, has acquired 2 FDA-approved products from Clonmel Healthcare, Ltd., a Republic of Ireland corporation. ...

India-based pharmaceutical company signs supply agreement with U.S. company.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Lannett Company, Inc., (LCI) has signed an agreement with Unichem Laboratories Ltd. of India for the exclusive supply of one or more generic drug products. Under the terms of the agreement, Unichem...

Japan-based contract research organization launches operations in U.S.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Iberica Co., Ltd., of Japan announced the full-scale launch of its contract research organization operations in the U.S. Using its new location in New York as a base, Iberica plans to help small-...

Maker of OTC migraine therapy adds retailers, distributes stock dividend.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- GelStat Corp. (GSAC) announced that its first product, GelStat Migraine, is now available through ShopKo Stores, Inc., and Publix. The company also announced the distribution of its previously...

Oralin dossier submitted to the Ecuador Ministry of Public Health.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT), a buccal drug-delivery company, announced that, in furtherance of its previously announced joint venture with PharmaBrand, SA, the Oralin dossier has been submitted...

Pharma company announces share purchase plan, awards and legal update.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Novartis announced that it will offer a direct share purchase plan (DSPP) to investors in Switzerland, Liechtenstein, France and the United Kingdom, marking the first time such a program has been...

Pharma company reaffirms value of U Share Card and receives approval for Lyrica.
October 1, 2004... 2004 OCT 1 - (NewsRx.com & NewsRx.net) -- In response to a New York Times story on the Pfizer for Living Share Card, Pfizer issued the following statement: Pfizer reaffirms its commitment to making its medicines available for free or at a...